# Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis

> **NCT03264716** · NA · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 5 (actual)

## Conditions studied

- Unresectable Colorectal Liver Metastasis

## Interventions

- **DEVICE:** HepaSphere TACE (transarterial chemoembolization)

## Key facts

- **NCT ID:** NCT03264716
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-31
- **Primary completion:** 2018-01-26
- **Final completion:** 2018-09-11
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03264716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03264716, "Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03264716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*